Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Levodopa-Induced Dyskinesias in Parkinson's Disease
NCT00477802Phase 4Terminated
- Sponsor
- University of Cincinnati
- Start
- May 2007
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in levodopa-induced dyskinesia (LID), sponsored by University of Cincinnati. Started May 2007; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00477802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477802.